A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
CRISPR Therapeutics
University of Pennsylvania
Prelude Therapeutics
Quadriga Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
Kantonsspital Winterthur KSW
GOG Foundation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)